Son Kyung-Bok
College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do, South Korea.
Expert Rev Pharmacoecon Outcomes Res. 2025 Jan;25(1):53-61. doi: 10.1080/14737167.2024.2388815. Epub 2024 Aug 6.
This study quantified the public value (PV) of the criteria and sub-criteria in the current drug reimbursement systems in South Korea and examined sociodemographic factors that associated with PV.
The Analytic Hierarchy Process (AHP) was used to quantify the PVs of criteria and sub-criteria. We developed a questionnaire to generate pairwise comparison matrices among criteria and sub-criteria. From 27 March to 1 April 2023, we recruited 1,000 study participants using a quota sampling method stratified by age, sex, and region based on Korean census data.
The PVs for the criteria were highest for clinical usefulness (28.5%), followed by cost-effectiveness (27.1%), budget impact (24.3%), and reimbursement in other countries (20.1%). The sociodemographic characteristics of the participants had a significant impact on the PVs of the criteria. Willingness to pay additional premiums for national health insurance was negatively associated with PV for clinical usefulness and cost-effectiveness and positively associated with PV for reimbursement in other countries.
The public prioritized clinical usefulness and cost-effectiveness as the main criteria. However, the PVs of the criteria were divergent and associated with sociodemographic factors. Divergent public interests require an evidence-informed deliberative process for reimbursement decisions.
本研究对韩国现行药品报销系统中标准和子标准的公共价值（PV）进行了量化，并考察了与公共价值相关的社会人口学因素。
采用层次分析法（AHP）对标准和子标准的公共价值进行量化。我们编制了一份问卷，以生成标准和子标准之间的成对比较矩阵。2023年3月27日至4月1日，我们基于韩国人口普查数据，采用按年龄、性别和地区分层的配额抽样方法招募了1000名研究参与者。
各标准的公共价值中，临床实用性最高（28.5%），其次是成本效益（27.1%）、预算影响（24.3%）和其他国家的报销情况（20.1%）。参与者的社会人口学特征对标准的公共价值有显著影响。愿意为国民健康保险支付额外保费与临床实用性和成本效益的公共价值呈负相关，与其他国家报销情况的公共价值呈正相关。
公众将临床实用性和成本效益作为主要标准。然而，这些标准的公共价值存在差异，并与社会人口学因素相关。不同的公共利益要求在报销决策过程中采用基于证据的审议程序。
